Plasma C-reactive protein and risk of cancer: A prospective study from Greece

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 2, 2006, Pages 381-384

  Trichopoulos, Dimitrios ^a   Psaltopoulou, Theodora ^b   Orfanos, Philippos ^b   Trichopoulou, Antonia ^b   Boffetta, Paolo ^c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER EPIDEMIOLOGY; CANCER RISK; DISEASE MARKER; FEMALE; FOLLOW UP; GREECE; HUMAN; INFLAMMATION; KIDNEY CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SKIN CANCER;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; FEMALE; GREECE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; RISK; TUMOR MARKERS, BIOLOGICAL;

EID: 33644802473     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0626     Document Type: Article

References (24)

1. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
2. Schacter E, Weitzman SA. Chronic inflammation and cancer. Oncology 2002;16:217-26.
3. IARC. Hepatitis viruses. In: IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 59. Lyon (France): IARC; 1994.
4. IARC. Infection with liver flukes. In: IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 61. Schistosomes, liver flukes and Helicobacter pylori. Lyon (France): IARC; 1994. p. 121-75.
5. Baron JA, Sandler RS. Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu Rev Med 2000;51:511-23.
6. Castell JV, Gomez-Lechon MJ, David M, Hirano T, Kishimoto T, Heinrich PC. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 1988; 232:347-50.
7. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998;128:127-37.
8. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
9. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-9.
10. Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999; 106:506-12.
11. Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ. C-reactive protein and the risk of incident colorectal cancer. JAMA 2004;291:585-90.
12. McSorley MA, Alberg AJ, Allen NE, et al. A collaborative study of the association between C-reactive protein concentrations and subsequent ovarian cancer risk [abstract 4376]. 96th Annual Meeting of the American Association for Cancer Research; 2005; Anaheim, California.
13. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003;348:2599-608.
14. Senju O, Takagi Y, Uzawa R, et al. A new immunoquantitative method by latex agglutination -Application for the determination of serum C-reactive protein (CRP) and its clinical significance. J Clin Lab Immunol 1986;19:99-103.
15. WHO. International Statistical Classification of Diseases and Related Health Problems (ICD, vol. 1,2,3). 10th Revision. Geneva (Switzerland): WHO; 1992.
16. WHO. International Classification of Diseases for Oncology. 2nd Revision. Geneva (Switzerland): WHO; 1990.
17. STATA Corporation. Intercooled Stata 7.0 for Windows 98/95/NT. College Station (Texas): STATA Corp.; 2002.
18. Levin B. Inflammatory bowel disease and colon cancer. Cancer 1992;50:1313-6.
19. Zhang SM, Buring JE, Lee IM, Cook NR, Ridker PM. C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med 2005;142:425-32.
20. Platz EA, De Marzo AM, Erlinger TP, et al. No association between pre-diagnostic plasma C-reactive protein concentration and subsequent prostate cancer. Prostate 2004;59:393-400.
21. Rifai N, Buring JE, Lee IM, Manson JE, Ridker PM. Is C-reactive protein specific for vascular disease in women? Ann Intern Med 2002;136:529-33.
22. US Department of Health and Human Services. The health consequences of smoking: chronic obstructive disease. A report of the surgeon general. DHHS publication no. (PHS) 84-50205. Washington (District of Columbia): U.S. Government Printing Office; 1984.
23. Kogevinas M, Trichopoulos D. Urinary bladder cancer. In: Adami HO, Hunter D, Trichopoulos D, editors. Textbook of cancer epidemiology. New York: Oxford University Press; 2002. p. 446-66.
24. Clarke R, Shipley M, Lewington S, et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 1999;150:341-53.